Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Average Price Target from Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received a consensus rating of “Hold” from the five research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $4.00.

BIOX has been the subject of several recent research reports. Wall Street Zen upgraded Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Canaccord Genuity Group dropped their target price on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research report on Friday, January 2nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Monday, December 29th.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Ardsley Advisory Partners LP lifted its stake in shares of Bioceres Crop Solutions by 4.7% in the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after purchasing an additional 45,000 shares during the last quarter. Ballast Asset Management LP raised its holdings in Bioceres Crop Solutions by 69.9% during the third quarter. Ballast Asset Management LP now owns 745,030 shares of the company’s stock valued at $1,048,000 after buying an additional 306,624 shares in the last quarter. Marshall Wace LLP lifted its position in shares of Bioceres Crop Solutions by 180.0% in the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after buying an additional 382,744 shares during the last quarter. GAM Holding AG acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter worth about $655,000. Finally, Susquehanna International Group LLP bought a new stake in shares of Bioceres Crop Solutions during the 3rd quarter worth about $315,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Stock Up 3.8%

Bioceres Crop Solutions stock opened at $0.54 on Monday. Bioceres Crop Solutions has a twelve month low of $0.40 and a twelve month high of $5.40. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.64 and a current ratio of 0.94. The firm has a market cap of $34.14 million, a PE ratio of -0.64 and a beta of 0.53. The firm’s 50 day moving average price is $0.95 and its two-hundred day moving average price is $1.54.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.